FDA Drug Application (017813) for LIBRELEASE by VALEANT PHARM INTL

Back to FDA Applications sponsored by VALEANT PHARM INTL

Application Number017813
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLIBRELEASE
Active IngredientCHLORDIAZEPOXIDE

Active IngredientCount
List of drugs with Active Ingredient CHLORDIAZEPOXIDE8


Back to FDA Applications sponsored by VALEANT PHARM INTL